Principal Financial Group
IMVT icon

Principal Financial Group’s Immunovant IMVT Stock Holding History

Principal Financial Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
+6,525
New +$199K ﹤0.01% 2066
2025
Q2 		– Sell
-760,608
Closed -$13M – 2268
2025
Q1 		$13M Sell
760,608
-31,255
-4% -$654K 0.01% 1114
2024
Q4 		$19.6M Sell
791,863
-159,261
-17% -$4.52M 0.01% 861
2024
Q3 		$27.1M Buy
951,124
+391,436
+70% +$11.5M 0.01% 682
2024
Q2 		$14.8M Sell
559,688
-23,033
-4% -$655K 0.01% 1047
2024
Q1 		$18.8M Buy
582,721
+142,606
+32% +$5.2M 0.01% 944
2023
Q4 		$18.5M Buy
440,115
+113,040
+35% +$4.16M 0.01% 925
2023
Q3 		$12.6M Buy
327,075
+303,707
+1,300% +$6.86M 0.01% 1093
2023
Q2 		$443K Sell
23,368
-684
-3% -$12.8K ﹤0.01% 1980
2023
Q1 		$373K Buy
24,052
+1,319
+6% +$22.9K ﹤0.01% 2037
2022
Q4 		$404K Buy
22,733
+4,896
+27% +$61.6K ﹤0.01% 2025
2022
Q3 		$99K Buy
17,837
+2,510
+16% +$12.3K ﹤0.01% 2336
2022
Q2 		$60K Buy
15,327
+2,293
+18% +$9.9K ﹤0.01% 2448
2022
Q1 		$72K Sell
13,034
-734
-5% -$4.57K ﹤0.01% 2458
2021
Q4 		$117K Sell
13,768
-5,694
-29% -$47K ﹤0.01% 2426
2021
Q3 		$169K Sell
19,462
-3,155
-14% -$28.5K ﹤0.01% 2452
2021
Q2 		$239K Buy
22,617
+3,094
+16% +$43.2K ﹤0.01% 2425
2021
Q1 		$313K Sell
19,523
-8,121
-29% -$214K ﹤0.01% 2265
2020
Q4 		$1.28M Buy
+27,644
New +$1.28M ﹤0.01% 1888

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Principal Financial Group's IMVT Position: Q2 2026 in Review

Principal Financial Group opened a new position in Immunovant (IMVT) in Q2 2026: 6,525 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #2066 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in IMVT as recently as Q1 2025.

Principal Financial Group first reported a position in IMVT in Q4 2020 and has held it in 19 quarters since. The position peaked at $27.1M in Q3 2024. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Principal Financial Group held 6,525 shares of Immunovant worth $251K as of Q2 2026.
  • Immunovant was a new Principal Financial Group position in Q2 2026.
  • Immunovant made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2066 holding.
  • Principal Financial Group first reported a position in Immunovant in Q4 2020 and has held it in 19 quarters since.
  • Principal Financial Group's Immunovant position peaked at $27.1M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.